12.04.2012 12:35 Uhr, Quelle: Wallstreet online

DGAP-News: Raptor Pharmaceutical Receives Notices of Allowance for Key European Patent Applications Protecting Its Cysteamine Portfolio (deutsch)

Raptor Pharmaceutical Receives Notices of Allowance for Key European Patent Applications Protecting Its Cysteamine Portfolio Raptor Pharmaceutical Corp. 12.04.2012 …

Weiterlesen bei Wallstreet online